Atlas Trials

Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

Clinical trial NCT01526694 · COMPLETED

Trial details

NCT number
NCT01526694
Sponsor
Azienda Ospedaliera di Bolzano
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-07-01
Primary completion
2015-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.